Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
Quintela-Fandino, Miguel, Apala, Juan V., Malon, Diego, Mouron, Silvana, Hornedo, Javier, Gonzalez-Cortijo, Lucia, Colomer, Ramon, Guerra, JuanVolume:
21
Journal:
Breast Cancer Research
DOI:
10.1186/s13058-019-1152-x
Date:
December, 2019
Fichier:
PDF, 1.27 MB
2019